BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1980342)

  • 41. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation.
    Hegi ME; Devereux TR; Dietrich WF; Cochran CJ; Lander ES; Foley JF; Maronpot RR; Anderson MW; Wiseman RW
    Cancer Res; 1994 Dec; 54(23):6257-64. PubMed ID: 7954475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison between the allelic frequency distribution of the Ha-ras 1 locus in normal individuals and patients with lymphoma, breast, and ovarian cancer.
    Corell B; Zoll B
    Hum Genet; 1988 Jul; 79(3):255-9. PubMed ID: 2841224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Increased risk of occurrence of pulmonary adenocarcinoma in man is associated with the presence of rare alleles of the Hras1 minisatellite].
    Gaspar'ian AV; Zborovskaia IB; Mukeriia AF; Tatosian AG; Zaridze DG
    Genetika; 1998 Nov; 34(11):1537-41. PubMed ID: 10096029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphism of p53 gene in Jordanian population and possible associations with breast cancer and lung adenocarcinoma.
    Mahasneh AA; Abdel-Hafiz SS
    Saudi Med J; 2004 Nov; 25(11):1568-73. PubMed ID: 15573180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ha-ras restriction fragment length polymorphisms in colorectal cancer.
    Wyllie FS; Wynford-Thomas V; Lemoine NR; Williams GT; Williams ED; Wynford-Thomas D
    Br J Cancer; 1988 Feb; 57(2):135-8. PubMed ID: 2896015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A method to analyze allele-specific methylation.
    Bedford MT; van Helden PD
    Biotechniques; 1990 Dec; 9(6):744-8. PubMed ID: 1980196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased frequency of specific alleles of the c-Ha-ras gene in Japanese cancer patients.
    Honda K; Ishizaki K; Ikenaga M; Toguchida J; Inamoto T; Tanaka K; Ozawa K
    Hum Genet; 1988 Aug; 79(4):297-300. PubMed ID: 2900800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.
    Klingel R; Mittelstaedt P; Dippold WG; Meyer zum Büschenfelde KH
    Gut; 1991 Dec; 32(12):1508-13. PubMed ID: 1685466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.
    Zborovskaya I; Gasparian A; Kitaeva M; Polotzky B; Tupitzin N; Machaladze Z; Gerasimov S; Shtutman M; Jakubovskaya M; Davidov M; Tatosyan A
    Clin Exp Metastasis; 1996 Nov; 14(6):490-500. PubMed ID: 8970579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of correlation between rare Ha-ras alleles and urothelial cancer in Japan.
    Ishikawa J; Maeda S; Takahashi R; Kamidono S; Sugiyama T
    Int J Cancer; 1987 Oct; 40(4):474-8. PubMed ID: 2889677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.
    Ryberg D; Tefre T; Skaug V; Stangeland L; Ovrebø S; Naalsund A; Børresen AL; Haugen A
    Environ Health Perspect; 1992 Nov; 98():187-9. PubMed ID: 1362538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deletion of the c-Ha-ras-1 allele in human skin cancers.
    Ananthaswamy HN; Applegate LA; Goldberg LH; Bales ES
    Mol Carcinog; 1989; 2(5):298-301. PubMed ID: 2690853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent occurrence of Ha-rasl allelic deletion in human ovarian adenocarcinomas.
    Viel A; De Pascale L; Toffoli G; Tumiotto L; Miotto E; Boiocchi M
    Tumori; 1991 Feb; 77(1):16-20. PubMed ID: 1708177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Association studies in cancerology: the example of gene L-myc polymorphism associated with the incidence of pulmonary metastases in breast cancers].
    Champème MH; Bièche I; Latil A; Hacène K; Lidereau R
    Bull Cancer; 1992; 79(12):1149-57. PubMed ID: 1304834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Racial variation in the distribution of Ha-ras-1 alleles.
    Weston A; Vineis P; Caporaso NE; Krontiris TG; Lonergan JA; Sugimura H
    Mol Carcinog; 1991; 4(4):265-8. PubMed ID: 1714739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response to radiotherapy of human uterine cervix carcinoma is not correlated with rearrangements of the Ha-ras-1 and/or c-myc genes.
    Polischouk AG; Scotnikova OI; Sergeeva NS; Zharinov GM; Lewensohn R; Zhivotovsky B
    Eur J Cancer; 1997 May; 33(6):942-9. PubMed ID: 9291819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphism of the c-Ha-ras-1 proto-oncogene in sporadic and familial breast cancer.
    Barkardóttir RB; Jóhannsson OT; Arason A; Gudnason V; Egilsson V
    Int J Cancer; 1989 Aug; 44(2):251-5. PubMed ID: 2668204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [An increased frequency of allele A6 of the proto-oncogene HRAS1 in cancer patients].
    Nikiforova IF; Pluzhnikova GF; Serova OM; Kniazev PG
    Vopr Onkol; 1991; 37(6):700-5. PubMed ID: 1843147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.